GPT Healthcare Q1FY27: Revenue Up 18% to ₹126.2 Cr, PAT Jumps 65.7%
GPT Healthcare reported Q1 FY27 results with Revenue up 18.0% YoY to ₹126.2 Cr and PAT up 65.7% YoY to ₹12.7 Cr. EBITDA rose 38.5% to ₹26.2 Cr. ARPOB increased to ₹42,350. The company plans to expand capacity to over 1,000 beds in two years and targets a Jamshedpur hospital commissioning by end-FY27.
The announcement contains significant financial results (revenue, PAT, EBITDA growth), strategic expansion plans (capacity increase, new hospital commissioning), and operational improvements (ARPOB, occupancy targets), which are material for investors.
The company reported strong year-on-year growth in revenue and profit, along with improved EBITDA and margins, indicating a positive financial performance.
GPT Healthcare Limited has announced its Unaudited Financial Results for the 1st quarter ended June 30, 2026. The company reported a significant increase in revenue from operations, which grew by 18.0% year-on-year to ₹126.2 crore. Profit After Tax (PAT) saw a substantial jump of 65.7% to ₹12.7 crore, with PAT Margin improving to 9.9% from 7.1% in the same period last year.
EBITDA for the quarter increased by 38.5% to ₹26.2 crore, and the EBITDA margin improved to 20.4%. The company's operational performance remained healthy, with Average Revenue Per Occupied Bed (ARPOB) increasing to ₹42,350, driven by an improved clinical mix and operating efficiencies. Network occupancy stood at 45.5% (excluding Raipur). Mature hospitals continued to deliver resilient performance, supported by steady patient footfalls.
Key strategic initiatives include expanding capacity to over 1,000 beds in the next two years and maintaining long-term ROCE of approximately 25%. The Jamshedpur hospital, a 155-bed facility with an investment of ₹75 crore, is targeted for commissioning by the end of FY27. The company is also planning entry into Tier II cities and select Tier I locations in Eastern India.
Operational enhancements include Agartala launching Comprehensive Cancer Care (PET scan + Linear Accelerator) and Howrah commencing robotic knee replacement surgeries, which are expected to increase ARPOB and reduce Average Length of Stay (ALOS). The company aims to ramp up occupancy at Agartala and Howrah from around 55% to 70-75%, unlocking margin expansion.
What to do with a filing like this
GPT Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by GPT Healthcare Limited. Read the original for the full detail.